ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Evolutionary Genomics Inc Common Stock (CE)

Evolutionary Genomics Inc Common Stock (CE) (FNAM)

0.0008
0.00
(0.00%)
Closed October 01 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0008
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.0008 52 Week Range 0.45
Market Cap
Previous Close
0.0008
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
5,277
Shares Outstanding
6,655,232
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.34
Revenue
-
Net Profit
-2.25M

About Evolutionary Genomics Inc Common Stock (CE)

The company engages in agricultural research. The company engages in agricultural research.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Las Vegas, Nevada, USA
Founded
-
Evolutionary Genomics Inc Common Stock (CE) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker FNAM. The last closing price for Evolutionary Genomics In... (CE) was $0. Over the last year, Evolutionary Genomics In... (CE) shares have traded in a share price range of $ 0.0008 to $ 0.45.

Evolutionary Genomics In... (CE) currently has 6,655,232 shares outstanding. The market capitalization of Evolutionary Genomics In... (CE) is $5,324.19 . Evolutionary Genomics In... (CE) has a price to earnings ratio (PE ratio) of 0.00.

FNAM Latest News

CREDIT MARKETS: 'Risk On' Aids Corporates, Lifts Safe-Haven Yields

The global search for yield drove money into bank bonds and lifted safe-haven yields Friday. The benchmark 10-year Treasury yield jumped nearly five basis points Friday to finish the week at...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00080.00080.000800CS
4000.00080.00080.000800CS
12000.00080.00080.000852770.0008CS
26-0.4492-99.82222222220.450.450.000826390.0008CS
52-0.4492-99.82222222220.450.450.000826390.0008CS
156-0.7992-99.90.80.90.000815830.58578104CS
260-1.4992-99.94666666671.55.710.000815450.90753182CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ONPHOncology Pharma Inc (CE)
$ 0.004
(399,900.00%)
6.48k
NEOMNeoMedia Technologies Inc (CE)
$ 0.0019
(189,900.00%)
9.01M
QTXBQuantRx Biomedical Corporation (CE)
$ 0.0015
(149,900.00%)
16k
TRLFFMaven Brands Inc (CE)
$ 0.001
(99,900.00%)
500
VAXXVaxxinity Inc (CE)
$ 0.08
(39,900.00%)
134
AXTLFAxtel SAB de CV (CE)
$ 0.000001
(-100.00%)
367
RVLWFRevitalist Lifestyle and Wellness Ltd (CE)
$ 0.000001
(-100.00%)
38.45k
REECFReece Ltd (PK)
$ 0.001
(-99.99%)
266
CLVRClever Leaves Holdings Inc (CE)
$ 0.000001
(-99.67%)
602
APPBApplied Biosciences Corporation (CE)
$ 0.000001
(-99.50%)
300
GRLTGrillit Inc (PK)
$ 0.0007
(133.33%)
430.94M
HMBLHUMBL Inc (PK)
$ 0.0003
(0.00%)
148.53M
GRLFGreen Leaf Innovations Inc (PK)
$ 0.0001
(0.00%)
138.68M
RDARRaadr Inc (PK)
$ 0.0006
(-25.00%)
92.05M
AXXAExxe Group Inc (PK)
$ 0.001
(-9.09%)
70.96M

FNAM Discussion

View Posts
adijas adijas 4 years ago
From last Q

Subsequent Events: The Company has evaluated all subsequent events through the date of this filing. On August 19, 2020, the Company entered into a Development and Commercialization Agreement with Dole Food Company for the development of plant varieties within the Musa genus of the Musaceae family (including the Cavendish variety of banana) that exhibit resistance to Fusarium Wilt Tropical Race 4 (popularly known as Panama Disease). Subject to compliance with various provisions of the agreement, the agreement includes working capital funding from Dole to the Company over the next four years. In addition to working capital funding, Dole will reimburse the Company for the development of banana plants and incur additional costs for the commercialization of plants upon successful completion of the development portion of this project. Per the Agreement, 50% of future royalties may be offset with the research funding provided by Dole. In the event that Dole terminates the agreement for material breach by the Company or the Companyโ€™s bankruptcy, the Company must repay all funding provided by Dole balances to Dole within six months of termination. The parties have agreed to negotiate the terms of the long-term license agreement upon successful completion of the development portion of this project.

Dole is huge https://en.wikipedia.org/wiki/Dole_Food_Company

๐Ÿ‘๏ธ0
RickNagra RickNagra 8 years ago
Looks like tomorrow could be epic.
๐Ÿ‘๏ธ0
tedpeele tedpeele 9 years ago
124k shares or 6m?
๐Ÿ‘๏ธ0
Renee Renee 9 years ago
Fona Inc. changed to Evolutionary Genomics Inc. and a one for 60.88 reverse split:

http://otce.finra.org/DLSymbolNameChanges
๐Ÿ‘๏ธ0
kranthikumar kranthikumar 11 years ago
FNAM is getting attension and momentum
๐Ÿ‘๏ธ0